Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696980 · ClinicalTrials.gov registry record · Phase 1
PEEP as Rescue Therapy for Asthmatics With Elevated BMI
A Phase 1 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02696980 is a Phase 1 study that has completed, run by University of Vermont. The registered enrollment target is 18 participants.
The verdict
NCT02696980, a Phase 1 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of increasing lung volume with a simple hand-held device to both prevent, and also to relieve, airway constriction in people with asthma and a BMI ≥ 30 kg/m2. Twenty people with late onset non-allergic asthma and a BMI of ≥ 30 kg/m2 will be recruited. The efficacy of elevating lung volume on both preventing and reversing bronchoconstriction will be tested. Lung volume will be modulated by breathing out against a small level of resistance (positive expiratory pressure).
Interventions
- DEVICE Positive Expiratory Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02696980
The ClinicalTrials.gov registry entry for NCT02696980 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positive Expiratory Pressure is the first listed.
NCT02696980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02696980 about?
NCT02696980 is a clinical study titled "PEEP as Rescue Therapy for Asthmatics With Elevated BMI". The purpose of this study is to test the effect of increasing lung volume with a simple hand-held device to both prevent, and also to relieve, airway constriction in people with asthma and a BMI ≥ 30 kg/m2. Twenty people with late onset non-allergic asthma and a BMI of ≥ 30 kg/m2 will be recruited....
What is the current status of trial NCT02696980?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2016-04. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02696980?
The interventions under investigation include: Positive Expiratory Pressure (DEVICE).
Who is sponsoring clinical trial NCT02696980?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.